Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge J Castillo

Showing results (271-280 of 343) with videos related to

Pageof 35
Sort By:
American Journal of Hematology|November 26, 2024
Autologous and Allogeneic Stem-Cell Transplantation for Transformed Waldenström MacroglobulinemiaEric Durot, Lukshe Kanagaratnam, Saurabh Zanwar, et al.
Hemasphere|August 18, 2020
Consensus Statement on the Management of Waldenström Macroglobulinemia Patients During the COVID-19 PandemicDipti Talaulikar, Ranjana H Advani, Andrew R Branagan, et al.
Blood Advances|April 15, 2026
Zanubrutinib and pirtobrutinib show synergistic killing and suppression of BTK signaling in MYD88-mutated lymphoma cellsDominic Pizzarella, Amanda Kofides, John M Hatcher, et al.
Blood|April 26, 2024
High efficacy of CD19 CAR T cells in patients with transformed Waldenström macroglobulinemiaEric Durot, Damien Roos-Weil, Adrien Chauchet, et al.
Seminars in Hematology|May 17, 2025
Report of Consensus Panel 4 from the 12th International Workshop on Waldenström's Macroglobulinemia on the management of patients with non-IgM lymphoplasmacytic lymphomaAlessandra Tedeschi, Rebecca Auer, Francesco Autore, et al.
Blood Advances|November 8, 2018
Insights into the genomic landscape of MYD88 wild-type Waldenström macroglobulinemiaZachary R Hunter, Lian Xu, Nickolas Tsakmaklis, et al.
American Journal of Hematology|December 24, 2019
Deepening of response after completing rituximab-containing therapy in patients with Waldenstrom macroglobulinemiaJorge J Castillo, Joshua N Gustine, Andrew Keezer, et al.
Hemasphere|July 22, 2021
Diagnostic Next-generation Sequencing Frequently Fails to Detect MYD88<sup>L265P</sup> in Waldenström MacroglobulinemiaAmanda Kofides, Zachary R Hunter, Lian Xu, et al.
American Journal of Hematology|April 5, 2021
Cell-free DNA analysis for detection of MYD88<sup>L265P</sup> and CXCR4<sup>S338X</sup> mutations in Waldenström macroglobulinemiaMaria G Demos, Zachary R Hunter, Lian Xu, et al.
American Journal of Hematology|July 24, 2019
Hematogenous extramedullary relapse in multiple myeloma - a multicenter retrospective study in 127 patientsIrit Avivi, Yael C Cohen, Anna Suska, et al.
Pageof 35

Showing results (271-280 of 343) with videos related to

Sort By:
Pageof 35
American Journal of Hematology|November 26, 2024
Autologous and Allogeneic Stem-Cell Transplantation for Transformed Waldenström MacroglobulinemiaEric Durot, Lukshe Kanagaratnam, Saurabh Zanwar, et al.
Hemasphere|August 18, 2020
Consensus Statement on the Management of Waldenström Macroglobulinemia Patients During the COVID-19 PandemicDipti Talaulikar, Ranjana H Advani, Andrew R Branagan, et al.
Blood Advances|April 15, 2026
Zanubrutinib and pirtobrutinib show synergistic killing and suppression of BTK signaling in MYD88-mutated lymphoma cellsDominic Pizzarella, Amanda Kofides, John M Hatcher, et al.
Blood|April 26, 2024
High efficacy of CD19 CAR T cells in patients with transformed Waldenström macroglobulinemiaEric Durot, Damien Roos-Weil, Adrien Chauchet, et al.
Seminars in Hematology|May 17, 2025
Report of Consensus Panel 4 from the 12th International Workshop on Waldenström's Macroglobulinemia on the management of patients with non-IgM lymphoplasmacytic lymphomaAlessandra Tedeschi, Rebecca Auer, Francesco Autore, et al.
Blood Advances|November 8, 2018
Insights into the genomic landscape of MYD88 wild-type Waldenström macroglobulinemiaZachary R Hunter, Lian Xu, Nickolas Tsakmaklis, et al.
American Journal of Hematology|December 24, 2019
Deepening of response after completing rituximab-containing therapy in patients with Waldenstrom macroglobulinemiaJorge J Castillo, Joshua N Gustine, Andrew Keezer, et al.
Hemasphere|July 22, 2021
Diagnostic Next-generation Sequencing Frequently Fails to Detect MYD88<sup>L265P</sup> in Waldenström MacroglobulinemiaAmanda Kofides, Zachary R Hunter, Lian Xu, et al.
American Journal of Hematology|April 5, 2021
Cell-free DNA analysis for detection of MYD88<sup>L265P</sup> and CXCR4<sup>S338X</sup> mutations in Waldenström macroglobulinemiaMaria G Demos, Zachary R Hunter, Lian Xu, et al.
American Journal of Hematology|July 24, 2019
Hematogenous extramedullary relapse in multiple myeloma - a multicenter retrospective study in 127 patientsIrit Avivi, Yael C Cohen, Anna Suska, et al.
Pageof 35